| A decrease in the severity of tics in children and adolescents with Tourette syndrome was observed following the use of ecopipam, according to data presented at the 2022 American Academy of Neurology annual meeting. “Our results are exciting, because they suggest ecopipam shows promise as a treatment for reducing the number, frequency and severity of the tics young p eople experience with Tourette syndrome,” study author Donald L. Gilbert, MD, AAN fellow and professor and neurologist at Cincinnati Children’s Hospital Medical Center, said in a released statement. “That’s especially true because many people with the disease who are taking the medications currently available still have debilitating symptoms or experience weight gain or other side effects.” |
585-730-8888
ddemarle@yahoo.com
